Shuwen Biotechnology Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C2

  • Investors
  • 10

Shuwen Biotechnology General Information

Description

Manufacturer of innovative in vitro diagnostic products focusing on women's health aims to lead global transformation in pregnancy and cancer screening. The company's offerings feature proprietary diagnostic assays for preeclampsia and breast cancer including the internationally pioneering Whanxian preeclampsia kit and prognostic test, accredited central laboratory services, certified IVD reagent production, and international collaborations, helping clinicians and pharmaceutical developers accelerate diagnosis, personalize treatment, and expand access to advanced womens health testing, enabling improved maternal and oncology outcomes worldwide.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 3, Number 333 Changhong Middle Street
  • Moganshan National High-tech Industrial Development Zone Deqing
  • Huzhou, Zhejiang 313200
  • China
+86 0572
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Corporate Office
  • Building 3, Number 333 Changhong Middle Street
  • Moganshan National High-tech Industrial Development Zone Deqing
  • Huzhou, Zhejiang 313200
  • China
+86 0572

Shuwen Biotechnology Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shuwen Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series C2) 09-Jul-2025 Completed Generating Revenue
6. Later Stage VC (Series C1) 09-Jul-2025 Completed Generating Revenue
5. Later Stage VC (Series B) 02-Jun-2021 Completed Generating Revenue
4. Later Stage VC (Series A1) 09-Apr-2018 Completed Generating Revenue
3. Later Stage VC 27-Jul-2017 Completed Generating Revenue
2. Later Stage VC (Series A) 01-Sep-2016 Completed Generating Revenue
1. Secondary Transaction - Private 29-Apr-2016 Completed Generating Revenue
To view Shuwen Biotechnology’s complete valuation and funding history, request access »

Shuwen Biotechnology Patents

Shuwen Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026114286-A1 Methods and devices for detection of anti-lipoidal antibodies Pending 26-Nov-2024
WO-2025146204-A1 Antibiotic-resistant neisseria mutant Inactive 04-Jan-2024
WO-2025119247-A1 A method for diagnosing or predicting preeclampsia Inactive 04-Dec-2023
WO-2023275407-A2 Method for predicting a clinical response towards an immune checkpoint inhibitor based on pretreatment therewith Inactive 02-Jul-2021
WO-2023275407-A3 Method for predicting a clinical response towards an immune checkpoint inhibitor based on pretreatment therewith Inactive 02-Jul-2021 C12Q1/6886
To view Shuwen Biotechnology’s complete patent history, request access »

Shuwen Biotechnology Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Zhangjiagang Yuefeng Jinchuang Investment Growth/Expansion Minority
Anyuan Fund Venture Capital Minority
CTRL Kaichuang Group Corporation Minority
Guolian Investment Corporate Venture Capital Minority
Wuxi Guolian Development (Group) Corporation Minority
You’re viewing 5 of 10 investors. Get the full list »

Shuwen Biotechnology FAQs

  • When was Shuwen Biotechnology founded?

    Shuwen Biotechnology was founded in 2010.

  • Where is Shuwen Biotechnology headquartered?

    Shuwen Biotechnology is headquartered in Huzhou, China.

  • What industry is Shuwen Biotechnology in?

    Shuwen Biotechnology’s primary industry is Diagnostic Equipment.

  • Is Shuwen Biotechnology a private or public company?

    Shuwen Biotechnology is a Private company.

  • What is Shuwen Biotechnology’s current revenue?

    The current revenue for Shuwen Biotechnology is .

  • How much funding has Shuwen Biotechnology raised over time?

    Shuwen Biotechnology has raised $29.5M.

  • Who are Shuwen Biotechnology’s investors?

    Zhangjiagang Yuefeng Jinchuang Investment, Anyuan Fund, CTRL Kaichuang Group, Guolian Investment, and Wuxi Guolian Development (Group) are 5 of 10 investors who have invested in Shuwen Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process